Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Plasma (single spun) (3)
• Saliva (3)
• Serum (4)
• Swab medium (4)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (6)

Storage Temperature

• -35°C to -18°C (3)
• -85°C to -60°C (4)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (4)
• Followup records (3)
• Freezer temperature logs (1)
• Genomic datasets (1)
• Imaging data (2)
• Microbiological results (6)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (2)
• Pre-analytical data (3)
• Quality indicators (3)
• Survey data (5)
• Treatment records (1)

Timeframe

• Immediate (1)
• 0 - 3 months (6)
• 3 - 6 months (1)
• > 6 months (1)

Participant Count

• 1 - 10 (1)
• 11 - 100 (4)
• 101 - 500 (3)
• 1001 - 3000 (1)

Sex

• Both sexes (6)

Age Range

• Young child (2 - 6 years) (3)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (4)
• Young adult (18 - 40 years) (6)
• Adult (> 40 years) (3)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Data analytics (2)
• Infectious strain isolation (2)
• Nucleic acid extraction (2)

Collection Type

• Case-control (1)
• Cross-sectional (1)
• Disease specific (5)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (6)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (6)
• No Scope of use restriction (3)

Collection Status

• Completed (2)
• In progress (4)

Access Condition

• Open to applicants (4)
• Open only through collaboration (1)
• Access restricted at present (2)

Country

• Belgium (1)
• Cameroon (1)
• Côte d'Ivoire (1)
• France (1)
• Peru (1)
• South Africa (1)

County